Literature DB >> 10779761

A VH11V kappa 9 B cell antigen receptor drives generation of CD5+ B cells both in vivo and in vitro.

M J Chumley1, J M Dal Porto, S Kawaguchi, J C Cambier, D Nemazee, R R Hardy.   

Abstract

B lymphocytes can be divided into different subpopulations, some with distinctive activation requirements and probably mediating specialized functions, based on surface phenotype and/or anatomical location, but the origins of most of these populations remain poorly understood. B cells constrained by transgenesis to produce an Ag receptor derived from a conventional (B-2) type cell develop a B-2 phenotype, whereas cells from mice carrying a B-1-derived receptor acquire the B-1 phenotype. In this study transgenic enforced expression of a B cell receptor (mu/kappa) originally isolated from a CD5+ (B-1a) B cell generates B-1 phenotype cells in bone marrow cultures that show a distinctive B-1 function, survival in culture. Despite their autoreactivity, we find no evidence for receptor editing or that the paucity of B-2 cells is the result of tolerance-induced selection. Finally, Ca2+ mobilization studies reveal a difference between transgenic B-1 cells in spleen and peritoneal cavity, with cells in spleen much more responsive to anti-B cell receptor cross-linking. We discuss these results in terms of specificity vs lineage models for generation of distinctive B cell subpopulations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779761     DOI: 10.4049/jimmunol.164.9.4586

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Age-dependent increase of peritoneal B-1b B cells in SCID mice.

Authors:  Kirk S Hinkley; Rod J Chiasson; Tracey K Prior; James E Riggs
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  X-chromosome-linked immune-deficient mice have B-1b cells.

Authors:  J Riggs; K Howell; B Matechin; R Matlack; A Pennello; R Chiasson
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

3.  Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3.

Authors:  Dennis C Otero; Valeria Poli; Michael David; Robert C Rickert
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 4.  Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

5.  Btk regulates multiple stages in the development and survival of B-1 cells.

Authors:  Cristina M Contreras; Kristina E Halcomb; Lindsey Randle; Rochelle M Hinman; Toni Gutierrez; Stephen H Clarke; Anne B Satterthwaite
Journal:  Mol Immunol       Date:  2007-01-04       Impact factor: 4.407

Review 6.  Mechanisms of central tolerance for B cells.

Authors:  David Nemazee
Journal:  Nat Rev Immunol       Date:  2017-04-03       Impact factor: 53.106

7.  Chronic lymphocytic leukemia: a tale of one or two signals?

Authors:  Nicholas Chiorazzi; Dimitar G Efremov
Journal:  Cell Res       Date:  2012-11-13       Impact factor: 25.617

8.  A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation.

Authors:  Rebecca A Sweet; Sean R Christensen; Michelle L Harris; Jonathan Shupe; Jaime L Sutherland; Mark J Shlomchik
Journal:  Autoimmunity       Date:  2010-04-07       Impact factor: 2.815

9.  Natural IgM is produced by CD5- plasma cells that occupy a distinct survival niche in bone marrow.

Authors:  Alexander E Reynolds; Masayuki Kuraoka; Garnett Kelsoe
Journal:  J Immunol       Date:  2014-11-26       Impact factor: 5.422

10.  Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling.

Authors:  Shih-Shih Chen; Franak Batliwalla; Nichol E Holodick; Xiao-Jie Yan; Sophia Yancopoulos; Carlo M Croce; Thomas L Rothstein; Nicholas Chiorazzi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.